COMIRNATY LP.8.1 30 mcg/dose ser pré 0.3 ml
7680704030010
CH-70403
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SUS
|
30.0 UG | Substance | Wirkstoff (Principe actif) |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
|
SUS
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 91.85
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2025
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 70403
- Drug name
- Comirnaty LP.8.1, Injektionsdispersion in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- J07BN01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 06/08/2025
- Authorization expiration date
- 05/08/2030
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- COMIRNATY LP.8.1 30 Mikrogramm sol inj 30 µg 1 pce
- Description (DE)
- COMIRNATY LP.8.1 30 Mikrogramm Inj Lös 30 µg 1 Stk
- Market launch
- 06/08/2025
- Narcotic (BTM)
- No